Improved Therapy by Pretargeted Radioimmunotherapy of Non-Hodgkin Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody

We examined whether a pretargeting method using a new, recombinant anti-CD20 bispecific antibody (bsMAb) followed by (90)Y-DOTA-peptide could reduce hematological toxicity yet improve therapeutic responses, compared to conventional (90)Y-anti-CD20 IgG and a chemically-conjugated bsMAb. TF4, a humani...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Sharkey, Robert M., Karacay, Habibe, Litwin, Samuel, Rossi, Edmund A., McBride, William J., Chang, Chein-Hsing, Goldenberg, David M.
格式: Artigo
語言:Inglês
出版: 2008
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2585743/
https://ncbi.nlm.nih.gov/pubmed/18593929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-0037
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍